The copper peptide the longevity world keeps coming back to.
GHK Cu peptide is a naturally occurring copper tripeptide that has been studied since Dr. Loren Pickart's work in the 1970s, and it is one of the most searched ingredients in skin and longevity care. GHK-Cu, also written as copper peptide GHK-Cu or GHK copper peptide, has been researched for skin remodeling, collagen signaling, wound repair, and hair follicle support. HELiXVi connects you with a licensed US provider for an online consultation, and if GHK-Cu is clinically appropriate for you, a topical GHK-Cu preparation is compounded by a US state-licensed pharmacy and shipped discreetly. Topical GHK Cu is the primary form we offer; any injectable use is strictly prescriber-directed. GHK-Cu is usually considered alongside the rest of a plan, so it is worth reading how it fits into longevity and peptide therapy before you start. GHK-Cu is not FDA-approved, and approval of any prescription is never guaranteed.
GHK-Cu is a tripeptide (glycyl-L-histidyl-L-lysine) bound to a copper ion. It was first described by Dr. Loren Pickart in the 1970s, and since then it has been studied in cell, animal, and small-scale human research for skin remodeling, wound repair, and hair follicle support. Researchers have examined its influence on collagen synthesis pathways, antioxidant activity, and gene expression patterns associated with tissue maintenance. It is important to be straightforward about the evidence: much of the research is preclinical or based on small human studies, and large-scale clinical trials are limited. GHK-Cu is not FDA-approved, and it is not presented as a treatment or cure for any condition. If you want to go deeper on a specific question, this hub links out to five detailed guides: GHK-Cu dosage explains how a clinician sets strength, frequency, and duration; GHK-Cu side effects covers reported reactions, copper metabolism cautions, and who should avoid it; GHK-Cu before and after sets out what controlled research actually measured instead of unverifiable photos; topical GHK-Cu covers serums, creams, concentration, and how copper peptides layer with other actives; and GHK-Cu peptide injection explains why the injectable route is clinician-directed only.
GHK-Cu is not a miracle, and anyone selling it as one is not being honest with you. What it is: a naturally occurring peptide with a longer research history than almost anything else in the copper peptide category, and a sensible, prescriber-guided option for people who take skin and hair support seriously. If you are weighing it against other protocols, our HELiXVi longevity programs page shows where copper peptides sit in the wider picture.
GHK-Cu is a naturally occurring copper tripeptide: three amino acids bound to a copper ion. It occurs in human plasma and has been studied since the 1970s for skin remodeling, collagen signaling, wound repair, and hair follicle support. It is often called copper peptide GHK-Cu or GHK copper peptide.
In published research, GHK-Cu has been examined for its influence on collagen and glycosaminoglycan pathways, antioxidant activity, and skin appearance. Most evidence is preclinical or from small human studies, so claims should be read with that context. It is not approved to treat or cure any condition.
No. GHK-Cu is not FDA-approved for any use. Compounded GHK-Cu preparations are made by US state-licensed compounding pharmacies for an individual prescription, and compounded medications are not FDA-approved. Be cautious of any seller implying otherwise.
There is no single standard dose, because dosage depends on the form, the concentration, and your goals. For topical GHK-Cu, your prescriber sets the strength and how often you apply it. Any dosing decision is made by your provider after reviewing your health profile.
We do not publish one, on purpose. Injectable GHK-Cu dosing is set and directed by the prescribing clinician for an individual patient, and a public self-dosing chart would invite unsupervised use, which is exactly what we do not support. If injection is ever considered, it is a prescriber-directed decision, not a DIY protocol.
Reported side effects are generally mild and depend on the form. Topical use can cause skin irritation, redness, or itching in some people. Because large-scale human safety data is limited, your provider reviews your skin history and overall health before prescribing and monitors how you respond.
Topical GHK-Cu is applied to the skin and is the form most consistent with the published skin and hair research, which is why it is the primary form HELiXVi offers. Injectable GHK-Cu has far less human evidence behind it, and when it is considered at all, it is directed by the prescriber only. We do not provide self-administration instructions.
The honest answer is that published before and after evidence comes from research settings, not marketing photos. Small studies have examined changes in skin appearance measures over weeks of topical use, but results vary widely and large trials are limited. We do not publish patient photos or promise outcomes, and individual results vary.
Administration route and site are decided and directed by the prescribing clinician, not by a web page. Topical application to the face, scalp, or target area is the standard route for the preparations HELiXVi prescribes. If a provider ever considers injection, they direct where and how; we do not publish self-administration guidance.
GHK-Cu is not FDA-approved. Compounded GHK-Cu preparations are prepared by US state-licensed pharmacies and are not FDA-approved. Prescription products require an online consultation with a licensed US provider; approval is not guaranteed. Research on GHK-Cu is largely preclinical and small-scale in humans. Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary.
Start your free consultation right now
No clinic visit. Licensed US clinicians. Dispatched within 24 hours of your consultation and payment.